Sakar Healthcare Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Sakar Healthcare.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 17.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think
Oct 30
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?
Dec 28Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?
Aug 05Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?
Mar 29Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors
Jan 31Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?
Dec 01Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet
Jul 13Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet
Mar 26With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting
Jul 01Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today
Mar 23Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares
Mar 02Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Feb 08Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?
Jan 10Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock
Dec 14Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?
Nov 22
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sakar Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 1,650 | 124 | -55 | 488 | N/A |
| 6/30/2024 | 1,555 | 112 | N/A | N/A | N/A |
| 3/31/2024 | 1,542 | 117 | -351 | 245 | N/A |
| 12/31/2023 | 1,518 | 125 | N/A | N/A | N/A |
| 9/30/2023 | 1,480 | 144 | -475 | 163 | N/A |
| 6/30/2023 | 1,438 | 127 | N/A | N/A | N/A |
| 3/31/2023 | 1,342 | 128 | -489 | 333 | N/A |
| 12/31/2022 | 1,302 | 178 | N/A | N/A | N/A |
| 9/30/2022 | 1,265 | 139 | -568 | 352 | N/A |
| 6/30/2022 | 1,265 | 144 | N/A | N/A | N/A |
| 3/31/2022 | 1,291 | 152 | -109 | 246 | N/A |
| 12/31/2021 | 1,139 | 80 | N/A | N/A | N/A |
| 9/30/2021 | 1,109 | 97 | -284 | 368 | N/A |
| 6/30/2021 | 1,054 | 118 | N/A | N/A | N/A |
| 3/31/2021 | 953 | 107 | -210 | 146 | N/A |
| 12/31/2020 | 913 | 118 | N/A | N/A | N/A |
| 9/30/2020 | 870 | 122 | -219 | -50 | N/A |
| 6/30/2020 | 884 | 106 | N/A | N/A | N/A |
| 3/31/2020 | 839 | 96 | 55 | 189 | N/A |
| 12/31/2019 | 851 | 88 | N/A | N/A | N/A |
| 9/30/2019 | 844 | 86 | N/A | N/A | N/A |
| 6/30/2019 | 744 | 78 | N/A | N/A | N/A |
| 3/31/2019 | 688 | 67 | -88 | 161 | N/A |
| 3/31/2018 | 534 | 38 | N/A | 53 | N/A |
| 3/31/2017 | 447 | 34 | N/A | 20 | N/A |
| 3/31/2016 | 414 | 22 | N/A | 92 | N/A |
| 12/31/2015 | 386 | 24 | N/A | 38 | N/A |
| 3/31/2015 | 350 | 18 | N/A | 42 | N/A |
| 3/31/2014 | 297 | 18 | N/A | 86 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SAKAR's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if SAKAR's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if SAKAR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if SAKAR's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if SAKAR's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SAKAR's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 02:41 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sakar Healthcare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|